NASD · Healthcare · Medical Devices · USA
Sensus Healthcare Inc is a micro cap company (market value under $300 million) in the Medical Devices industry.
Sensus Healthcare develops medical devices for treating non-melanoma skin cancer and keloid scars using proprietary low-energy X-ray technology. The company offers the SRT-100, SRT-100+, and SRT-100 Vision systems to dermatologists and radiation oncologists, along with service agreements, consumables, and financing options for equipment acquisition.
From its FY2025 annual report (Form 10-K)
Intrinsic value, DCF valuation, financial health and value investing analysis for the Sensus Healthcare Inc stock.
Slightly undervalued: intrinsic value $2.49 per share, market price $2.26, margin of safety 9.2% (as of 2026-11-17).
Its liquidation floor, current assets minus every liability, values the shares at $2.49; the price of $2.26 is 9% below that value.
7 more funds hold it; the full list is part of the paid plan.
All 140 Medical Devices stocks
10 more in this industry show a wider margin of safety.
SRTS is slightly undervalued (as of the 2026-11-17 close). Its liquidation floor, current assets minus every liability, values the shares at $2.49; the price of $2.26 is 9% below that value.
$2.49 per share (as of the 2026-11-17 close), against a market price of $2.26. That is a margin of safety of 9.2%. The value comes from the one valuation method that applies to this company, recomputed every night after the US close.